RFP
CGEM icon

Root Financial Partners’s Cullinan Oncology CGEM Stock Holding History

Root Financial Partners’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$881 Buy
+62
New +$797 ﹤0.01% 2663

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Root Financial Partners's CGEM Position: Q1 2026 in Review

Root Financial Partners opened a new position in Cullinan Oncology (CGEM) in Q1 2026: 62 shares worth $881. The stake represents ﹤0.01% of the portfolio and ranks #2663 among its holdings.

174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • Root Financial Partners held 62 shares of Cullinan Oncology worth $881 as of Q1 2026.
  • Cullinan Oncology was a new Root Financial Partners position in Q1 2026.
  • Cullinan Oncology made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2663 holding.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.